Management of blood pressure in primary care

BMJ (Online)

Volumn 338, Issue 7705, 2009, Pages 1219-

  McManus, Richard J ^a   Mant, Jonathan ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; EDITORIAL; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPERTENSIVE CRISIS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; STROKE; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; PRIMARY HEALTH CARE;

EID: 67650084309     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b940     Document Type: Editorial

References (13)

1. Keenan K, Hayen A, Neal BC, Irwig L. Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial. BMJ 2009;338:b1492.[Abstract/Free Full Text]
2. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665.[Abstract/Free Full Text]
3. Jackson R. Guidelines on preventing cardiovascular disease in clinical practice. BMJ 2000;320:659-61.[Free Full Text]
4. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.[CrossRef][Web of Science] [Medline]
5. National Institute for Health and Clinical Excellence. Hypertension: management of hypertension in adults in primary care. 2006. www.nice.org.uk/ guidance/index.jsp?action=byID&o=10986.
6. Mansia G, De BG, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press 2007;16:135-232.[CrossRef][Web of Science][Medline]
7. NHS Information Centre. Quality and Outcomes Framework 2006/07. Online GP practice results database. 2008. www.qof.ic.nhs.uk/.
8. McManus RJ, Mant J, Roalfe A, Oakes RA, Bryan S, Pattison HM, et al. Targets and self monitoring in hypertension: randomised controlled trial and cost effectiveness analysis. BMJ 2005;331:493. [Abstract/Free Full Text]
9. McManus RJ, Glasziou P, Hayen A, Mant J, Padfield P, Potter J, et al. Blood pressure self monitoring: questions and answers from a national conference. BMJ 2008;337:a2732.[Free Full Text]
10. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the second international consensus conference on home blood pressure monitoring. J Hypertens 2008;26:1505-26.[Web of Science][Medline]
11. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005;366:1545-53.[CrossRef][Web of Science][Medline]
12. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003;362:1527-35.[CrossRef][Web of Science][Medline]
13. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419.[Abstract/Free Full Text]